BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28058630)

  • 1. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.
    Fang Y; Zhao L; Xiao H; Cook KM; Bai Q; Herrick EJ; Chen X; Qin C; Zhu Z; Wakefield MR; Nicholl MB
    Med Oncol; 2017 Feb; 34(2):23. PubMed ID: 28058630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-39 acts as a friend to pancreatic cancer.
    Manning AA; Zhao L; Zhu Z; Xiao H; Redington CG; Ding VA; Stewart-Hester T; Bai Q; Dunlap J; Wakefield MR; Fang Y
    Med Oncol; 2018 Dec; 36(1):12. PubMed ID: 30506430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax.
    Balabanov D; Zhao L; Zhu Z; Hunzeker ZE; Tonner HM; Ding VA; Wakefield MR; Bai Q; Fang Y
    Anticancer Res; 2019 Jul; 39(7):3493-3498. PubMed ID: 31262873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
    Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
    Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL.
    Fang Y; Chen X; Bai Q; Qin C; Mohamud AO; Zhu Z; Ball TW; Ruth CM; Newcomer DR; Herrick EJ; Nicholl MB
    J Surg Oncol; 2015 Jun; 111(8):969-74. PubMed ID: 25988864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer.
    Seo JH; Jung KH; Son MK; Yan HH; Ryu YL; Kim J; Lee JK; Hong S; Hong SS
    Cancer Lett; 2013 Sep; 338(2):271-81. PubMed ID: 23587795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
    Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation.
    Yadav V; Varshney P; Sultana S; Yadav J; Saini N
    BMC Cancer; 2015 Aug; 15():581. PubMed ID: 26260159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
    Basu A; Haldar S
    Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
    Kato S; Shirato K; Imaizumi K; Toyota H; Mizuguchi J; Odawara M; Che XF; Akiyama S; Abe A; Tomoda A
    Oncol Rep; 2006 Apr; 15(4):843-8. PubMed ID: 16525669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Olive Biophenols Oleuropein and Hydroxytyrosol Selectively Reduce Proliferation, Influence the Cell Cycle, and Induce Apoptosis in Pancreatic Cancer Cells.
    Goldsmith CD; Bond DR; Jankowski H; Weidenhofer J; Stathopoulos CE; Roach PD; Scarlett CJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30004416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
    Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
    Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro.
    Fahrioğlu U; Dodurga Y; Elmas L; Seçme M
    Gene; 2016 Jan; 576(1 Pt 3):476-82. PubMed ID: 26516023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apoptotic and autophagic properties of two natural occurring prodrugs, hyperoside and hypoxoside, against pancreatic cancer cell lines.
    Boukes GJ; van de Venter M
    Biomed Pharmacother; 2016 Oct; 83():617-626. PubMed ID: 27459118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro interaction of human pancreatic cancer cells and rat dorsal root ganglia: a co-culture model].
    Liu ZS; Wang Y; Li Q; Zhang SL; Shi YR
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):259-63. PubMed ID: 22781036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol.
    Shibayama-Imazu T; Sakairi S; Watanabe A; Aiuchi T; Nakajo S; Nakaya K
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):1-11. PubMed ID: 12618894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.
    Okui N; Kamata Y; Sagawa Y; Kuhara A; Hayashi K; Uwagawa T; Homma S; Yanaga K
    Pancreatology; 2019 Jan; 19(1):88-96. PubMed ID: 30416041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M; Murata T
    Int J Mol Med; 2015 Jun; 35(6):1773-8. PubMed ID: 25847529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
    Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
    Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.